IMNM vs JCI · $2.47B cap vs P/E 44, rev $23.60B
Immunome Inc (IMNM) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
IMNM currently screens at market cap $2.47B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the IMNM and JCI stock pages for the full models.
Not investment advice.